学术探索
学术期刊
新闻热点
数据分析
智能评审

State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis

被引：25
作者：
Hoppe, JE [1 ]
机构：
[1] Univ Tubingen, Kinderklin, D-72070 Tubingen, Germany
来源：
INFECTION | 1998年 / 26卷 / 04期
关键词：
D O I：
10.1007/BF02962373
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：242 / 246
页数：5
相关论文
共 48 条
[21]  
HALPERIN SA, 1996, 36 INT C ANT AG CHEM, P267
[22]   COMPARATIVE INVITRO ACTIVITIES OF NEW 14-MEMBERED, 15-MEMBERED, AND 16-MEMBERED MACROLIDES [J].
HARDY, DJ ;
HENSEY, DM ;
BEYER, JM ;
VOJTKO, C ;
MCDONALD, EJ ;
FERNANDES, PB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1710-1719
[23]   Pertussis: Current concepts of pathogenesis and prevention [J].
Hewlett, EL .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (04) :S78-S84
[24]   INVITRO SUSCEPTIBILITIES OF BORDETELLA-PERTUSSIS AND BORDETELLA-PARAPERTUSSIS TO 6 NEW ORAL CEPHALOSPORINS [J].
HOPPE, JE ;
MULLER, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (07) :1442-1443
[25]   COMPARISON OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN ETHYLSUCCINATE FOR TREATMENT OF PERTUSSIS [J].
HOPPE, JE .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (03) :189-193
[26]   COMPARISON OF MEDIA FOR AGAR DILUTION SUSCEPTIBILITY TESTING OF BORDETELLA-PERTUSSIS AND BORDETELLA-PARAPERTUSSIS [J].
HOPPE, JE ;
TSCHIRNER, T .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (09) :775-779
[27]   ACTIVITY OF NEW MACROLIDES AGAINST BORDETELLA-PERTUSSIS AND BORDETELLA-PARAPERTUSSIS [J].
HOPPE, JE ;
EICHHORN, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (07) :653-654
[28]   INVITRO SUSCEPTIBILITIES OF BORDETELLA-PERTUSSIS AND BORDETELLA-PARAPERTUSSIS TO 7 FLUOROQUINOLONES [J].
HOPPE, JE ;
SIMON, CG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2287-2288
[29]   ANTIMICROBIAL SUSCEPTIBILITY OF BORDETELLA-PERTUSSIS .1. [J].
HOPPE, JE ;
HAUG, A .
INFECTION, 1988, 16 (02) :126-130
[30]   In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem [J].
Hoppe, JE ;
RahimiGalougahi, E ;
Seibert, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :807-808
12345